Loading
Latest filing published 30 Jun 2026 for Eupraxia Pharmaceuticals Inc..
No signal scores available.
This profile gathers the share dealings of Jeyanesh Tambiah in Eupraxia Pharmaceuticals Inc. Between 1 May 2026 and 25 June 2026, the trades on record add up to 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 30 June 2026 with a share grant in Eupraxia Pharmaceuticals Inc. Typically, a trade is published a median of 5 days after it takes place. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations